Estee Lauder international appointment
This article was originally published in The Rose Sheet
Executive Summary
Deborah Davidson to VP-international business development, responsible for global key brand initiatives, Estee Lauder announces. Reporting to Senior VP/Estee Lauder International General Manager Mark Loomis, Davidson's primary responsibilities will include development and execution of the International Spa and Skincare Centers and coordination of programs in Anglo markets with the North American team, firm says. Exec joined Lauder in 1982 and worked most recently as VP/national sales manager for Donna Karan Cosmetics...
You may also be interested in...
Alvotech Highlights Lack Of Simponi Rivals As It Delivers Golimumab Results
Alvotech has just become the first company to announce positive topline results from a confirmatory clinical study for a proposed golimumab rival to Simponi and Simponi Aria – and moreover, the firm sees limited competition from other biosimilars on the horizon.
Xbrane Assembles The Troops As FDA Says No To Lucentis Biosimilar
Xbrane Biopharma was riding the crest of a wave with the EU launch of its biosimilar to Lucentis, following years of toil and investment. However, plans to roll out the product in the US will have to be pushed back – likely – into the middle of 2025, following a US FDA complete response letter.
UK MHRA Updates Assistive Tech And Borderline Regulations
Device classification themes were uppermost in April for the UK regulator, which issued key guidance in two areas prone to complexities. It also contributed to the MedTech Directorate’s one-year progress report.